Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q1 2020 Earnings Conference Call May 14, 2020 8:30 AM ET
Company Participants
Allen Baharaff - Chairman, CEO & President
Yohai Stenzler - CFO & Controller
Liat Hayardeny - Chief Scientific Officer
Tali Gorfine - Chief Medical Officer
Conference Call Participants
Steve Seedhouse - Raymond James
Adam Walsh - Stifel
Kristen Kluska - Cantor Fitzgerald
Ed Arce - H.C. Wainwright
Mayank Mamtani - B. Riley FBR, Inc.
Operator
Good day. Welcome to Galmed’s Conference Call to discuss Financial Results for the First Quarter of 2020. Today's conference is being recorded.
Before we begin, please note that we will be making certain forward-looking statements on today's call, including those regarding financial results, statements and forecasts regarding anticipated timelines and expectations with respect to our regulatory and clinical development programs, as well as other statements that relate to future events.
These statements are based on the beliefs and expectations of management as of today, and actual results, trends, timelines and projections relating to our financial position and projected development programs, and pipeline could differ materially.
In particular there is significant uncertainty about the duration and severity of the COVID-19 pandemic, its impact on Galmed's business and operations. We urge all investors to read carefully the risk and uncertainties disclosed in our filings with the SEC, including, without limitation, the risks under the heading Risk Factors described in our annual report on Form 20-F filed with the SEC, and the risks and uncertainties included in the Form 6-K filed with the SEC earlier today. Galmed assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates only.
I would now like to turn the call over to Allen Baharaff, President and Chief Executive Officer. Allen, please go ahead.
Allen Baharaff
Thank you, Sherry. Good morning, and
- Read more current GLMD analysis and news
- View all earnings call transcripts